Related Experiment Video
Updated: Apr 22, 2026

07:43
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.2K
Elevated plasma IgG is associated with improved treatment response and survival in advanced non‑small cell lung
Ryotaro Ohkuma1,2,3, Nobuyuki Onishi3,4, Makoto Watanabe3,4
1Department of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan.
Scientific Reports
|April 20, 2026
Abstract
No abstract available in PubMed .
Keywords:
BiomarkerHumoral immunityImmune checkpoint inhibitorImmunoglobulin GNon-small cell lung cancerPD-1 blockadeMore Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.1K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
9.2K